Atrial fibrillation Trials in Chattanooga, United States
Conditions / Atrial fibrillation / Chattanooga, United States
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
21 total trials for this combination
Showing top 10 of 21 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05147792 | The CONFORM Pivotal Trial | RECRUITING | NA |
| NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | COMPLETED | PHASE3 |
| NCT05809596 | HEAL-LAA Clinical Trial | COMPLETED | NA |
| NCT01468701 | GLORIA-AF Registry Program - Second and Third Phases | COMPLETED | — |
| NCT05643573 | A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke | TERMINATED | PHASE3 |
| NCT04226547 | Amplatzer Amulet LAAO vs. NOAC | ACTIVE_NOT_RECRUITING | NA |
| NCT00279981 | TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics | COMPLETED | — |
| NCT04394546 | CHAMPION-AF Clinical Trial | ACTIVE_NOT_RECRUITING | NA |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00808067 | RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial | COMPLETED | PHASE3 |